Business Development Officer
James Timmins has been the Health Sciences Business Development Officer at UNLV since July 2016, with a focus on supporting the clinical and commercial advancement of the Nevada Institute of Personalized Medicine. Timmins was one of the first scientists and technically-trained MBAs (MIT Sloan School) in the biotech field, with startup roles for Promega and the biotech units of Upjohn, Amoco, and W.R. Grace, resulting in commercialized products and spinoff ventures. His recent career has focused on repeating this process for large nonprofit entities and/or scientists that have biotech assets to license or commercialize into new ventures.
Intellectual Property Assessment and Commercialization